Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia

Acta Neurologica Scandinavica

Volumn 93, Issue 2-3, 1996, Pages 133-137

  Isoe, K ^a   Urakami, K ^a   Sato, K ^a   Takahashi, K ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Apolipoprotein E; Dementia of the Alzheimer type; Skin fibroblast; Vascular dementia

Indexed keywords

APOLIPOPROTEIN E; MESSENGER RNA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; SKIN FIBROBLAST;

EID: 0030010322     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1996.tb00188.x     Document Type: Article

References (29)

1. MAHLEY RW. Apolipoprotein E, cholesterol transport protein with expanding role in cell biology. Science 1988: 240: 622-30.
2. KATAOKA S, PAIDI M, HOWARD BV. Simplified isoelectric focusing/immunoblotting, determination of apolipoprotein E phenotype. Clin Chem 1994: 40: 11-3.
3. POIRIER J, HESS M, MAY PC, FINCH CE. Astrocytic apolioprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol Brain Res 1991: 11: 97-106.
4. POIRIER J, BACCICHET A, DEA D, GAUTHIER S. Cholesterol synthesis and lipoprotein reuptake during synaptic remodeling in hippocampus in adult rats. Neuroscience 1993: 55: 81-90.
5. NAMBA Y, TOMONAGA M, KAWASAKI H, OTOMO E, IKEDA K. Apoliprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991: 541: 163-6.
6. WISNIEWSKI T, FRANGIONE B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992: 135: 235-8.
7. STRITTMATTER WJ, SAUNDERS AM, SCHMECHEL D et al. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 1993: 90: 1977-81.
8. SAUNDERS AM, SCHMADER K, BREITNER JCS et al. Apolioprotein ε4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming disease. Lancet 1993: 342: 710-1.
9. UEKI A, KAWANO M, NAMBA Y, KAWAKAMI M, IKEDA K. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett 1993: 163: 166-8.
10. CORDER EH, SAUNDERS WJ, STRITTMATTER WJ et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993: 261: 921-3.
11. SCHMECHEL DE, SAUNDERS AM, STRITTMATTER WJ et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A 1993: 90: 9649-53.
12. WISNIEWSKI T, GOLABEK A, MATSUBARA E, GHISO J, FRANGIONE B. Apolipoprotein E: binding to soluble Alzheimer's β-amyloid. Biochem Biophys Res Commun 1993: 192: 359-65.
13. TALBOT C, LENDON C, CRADDOCK N, SHEARS S, MORRIS JC, GOATE A. Protection against Alzheimer's disease with apoE ε2. Lancet 1994: 343, 1432-33.
14. BENJAMIN R, LEAKE A, MCARTHUR FK et al. Protective effect of apoE ε2 in Alzheimer's disease. Lancet 1994: 344: 473.
15. OKUIZUMI K, ONODERA O, TANAKA H ET AL. ApoE-ε4 and early-onset Alzheimer's. Nature Genet 1994: 7: 10-1.
16. SHIMANO H, ISHIBASHI S, MURASE T et al. Plasma apoliproteins in patients with multi-infarct dementia. Atherosclerosis 1989: 79: 257-60.
17. FRISONI GB, BIANCHETTI A, GOVONI S, TRABUCCHI M, CALABRESI L, FRANCESSCHINI G. Association of apoliprotein E ε4 with vascular dementia. JAMA 1994: 271: 1317.
18. SAKODA S, KURIYAMA M, OSAME M et al. Apoliprotein E ε4. Neurology 1994: 44: 2420.
19. DIEDRICH JF, MINNIGAN H, CARP RI et al. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apoliprotein E and cathepsin D in astrocytes. J Virol 1991: 65: 4759-68.
20. POIRIER J, HESS M, MAY PC, PASINETTI G, FINCH CE. Astroglial gene expression in the hippocampus following partial deafferenation in the rat and in Alzheimer's disease. In: NAGATSU T et al., ed. Basic clinical and therapeutic aspects of Alzheimer's and Parkinson's disease. New York: Plenum Press, 1991: 191-4.
21. OKADA A, URAKAMI K, TAKAHASHI K, OHNO K, SATO K, ENDO H. Expression of amyloid beta-protein precursor mRNAs in cultured skin fibrobrasts taken from patients with dementia of the Alzheimer type. Dementia 1994: 5: 55-6.
22. URAKAMI K, SATO K, OKADA A et al. Cu, Zn superoxide dismutase in patients with dementia of the Alzheimer type. Acta Neurol Scand 1995: 91: 165-8.
23. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and statistical manual of mental disorders. 3rd edn., revised. Washington, DC: APA, 1987: 101-7.
24. MCKHANN G, DRACHMAN D, FOLSTEIN M, KATZMAN R, PRICE D, STADLER EM. Clinical diagnosis of Alzheimer's disease. Neurology 1984: 34: 934-44.
25. HACHINSKI VC, ILLIF LD, ZILHKA E et al. Cerebral blood flow in dementia. Arch Neurol 1975: 32: 632-37.
26. CHUI HC, VICTOROFF JI, MARGOLIN D et al. Criteria for diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's disease diagnostic and treatment centers. Neurology 1992: 42: 473-80.
27. OHNO K, NAKANO C, EDA I et al. Fibroblasts from patients with myotonic musclar dystrophy: cholesterol requirement for proliferation and sensitivity to polyen antibiotics. Brain Dev 1984: 6: 556-70.
28. CHOMCZYNSKI P, SACCHI N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1986: 162: 156-9.
29. GOLDBERG DA. Isolation and partial characterization of the drosophila alcohol dehydrogenase gene. Proc Natl Acad Sci USA 1980: 77: 5749-98.